☰

Holly A. Stessman, Ph.D. - Publications

Affiliations: 
2013 Molecular, Cellular, Developmental Biology and Genetics University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology, Cell Biology, General Biology
Tree Info Similar researchers PubMed Report error

22/35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Duncan RM, Reyes L, Moats K, Robinson RM, Stessman HA, Dolloff NG. Abstract 3840: ATF3 drives synergy between protein disulfide isomerase (PDI) inhibitors and epigenetic cancer therapy Cancer Research. 79: 3840-3840. DOI: 10.1158/1538-7445.Am2019-3840  0.392
2016 Wang T, Guo H, Xiong B, Stessman HA, Wu H, Coe BP, Turner TN, Liu Y, Zhao W, Hoekzema K, Vives L, Xia L, Tang M, Ou J, Chen B, et al. De novo genic mutations among a Chinese autism spectrum disorder cohort. Nature Communications. 7: 13316. PMID 27824329 DOI: 10.1038/ncomms13316  0.348
2016 Mitra AK, Stessman HA, Schaefer RJ, Wang W, Myers CL, Van Ness BG, Beiraghi S. Fine-Mapping of 18q21.1 Locus Identifies Single Nucleotide Polymorphisms Associated with Nonsyndromic Cleft Lip with or without Cleft Palate. Frontiers in Genetics. 7: 88. PMID 27242896 DOI: 10.3389/fgene.2016.00088  0.522
2015 Turner TN, Hormozdiari F, Duyzend MH, McClymont SA, Hook PW, Iossifov I, Raja A, Baker C, Hoekzema K, Stessman HA, Zody MC, Nelson BJ, Huddleston J, Sandstrom R, Smith JD, et al. Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA. American Journal of Human Genetics. PMID 26749308 DOI: 10.1016/J.Ajhg.2015.11.023  0.336
2015 Mitra AK, Mukherjee UK, Harding T, Jang JS, Stessman H, Li Y, Abyzov A, Jen J, Kumar S, Rajkumar V, Van Ness B. Single-cell analysis of targeted transcriptome (SCATTome) predicts drug sensitivity of single cells within human myeloma tumors. Leukemia. PMID 26710886 DOI: 10.1038/Leu.2015.361  0.459
2015 Krumm N, Turner TN, Baker C, Vives L, Mohajeri K, Witherspoon K, Raja A, Coe BP, Stessman HA, He ZX, Leal SM, Bernier R, Eichler EE. Excess of rare, inherited truncating mutations in autism. Nature Genetics. 47: 582-8. PMID 25961944 DOI: 10.1038/Ng.3303  0.344
2015 Mitra AK, Mukherjee U, Harding T, Stessman H, Li Y, Jin J, Kumar SK, Rajkumar SV, Ness BGV. Scattome: A Single-Cell Analysis of Targeted Transcriptome Program to Predict Drug Sensitivity of Single Cells within Human Myeloma Tumors Blood. 126: 4249-4249. DOI: 10.1182/Blood.V126.23.4249.4249  0.503
2014 O'Roak BJ, Stessman HA, Boyle EA, Witherspoon KT, Martin B, Lee C, Vives L, Baker C, Hiatt JB, Nickerson DA, Bernier R, Shendure J, Eichler EE. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nature Communications. 5: 5595. PMID 25418537 DOI: 10.1038/Ncomms6595  0.334
2014 Fall DJ, Stessman H, Patel SS, Sachs Z, Van Ness BG, Baughn LB, Linden MA. Utilization of translational bioinformatics to identify novel biomarkers of bortezomib resistance in multiple myeloma. Journal of Cancer. 5: 720-7. PMID 25368671 DOI: 10.7150/Jca.9864  0.681
2014 Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, Smith JD, Paeper B, Nickerson DA, Dea J, Dong S, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 515: 216-21. PMID 25363768 DOI: 10.1038/Nature13908  0.341
2014 Stessman HA, Lulla A, Xia T, Mitra A, Harding T, Mansoor A, Myers CL, Van Ness BG, Dolloff NG. High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma. Leukemia. 28: 2263-7. PMID 25005244 DOI: 10.1038/leu.2014.214  0.621
2014 Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O, Witherspoon K, Gerdts J, Baker C, Vulto-van Silfhout AT, Schuurs-Hoeijmakers JH, Fichera M, Bosco P, Buono S, Alberti A, et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell. 158: 263-76. PMID 24998929 DOI: 10.1016/J.Cell.2014.06.017  0.336
2014 Stessman HA, Bernier R, Eichler EE. A genotype-first approach to defining the subtypes of a complex disease. Cell. 156: 872-7. PMID 24581488 DOI: 10.1016/J.Cell.2014.02.002  0.356
2014 Stessman HA, Mansoor A, Linden MA, Van Ness B, Baughn LB. Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency. Leukemia & Lymphoma. 55: 220-2. PMID 23734619 DOI: 10.3109/10428194.2013.797575  0.611
2014 Mitra AK, Stessman H, Linden MA, Van Ness B. Single-Cell Transcriptomics Identifies Intra-Tumor Heterogeneity in Human Myeloma Cell Lines Blood. 124: 3385-3385. DOI: 10.1182/Blood.V124.21.3385.3385  0.608
2013 Stessman HA, Mansoor A, Zhan F, Linden MA, Van Ness B, Baughn LB. Bortezomib resistance can be reversed by induced expression of plasma cell maturation markers in a mouse in vitro model of multiple myeloma. Plos One. 8: e77608. PMID 24204892 DOI: 10.1371/Journal.Pone.0077608  0.685
2013 Stessman HA, Mansoor A, Zhan F, Janz S, Linden MA, Baughn LB, Van Ness B. Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib. Leukemia. 27: 2075-7. PMID 23728080 DOI: 10.1038/Leu.2013.148  0.585
2013 Stessman HA, Baughn LB, Sarver A, Xia T, Deshpande R, Mansoor A, Walsh SA, Sunderland JJ, Dolloff NG, Linden MA, Zhan F, Janz S, Myers CL, Van Ness BG. Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model. Molecular Cancer Therapeutics. 12: 1140-50. PMID 23536725 DOI: 10.1158/1535-7163.Mct-12-1151  0.693
2013 Lulla A, Stessman H, Dicker D, Ness BV, El-Deiry W, Dolloff NG. Abstract 1020: VRC2, a novel bortezomib re-sensitizing compound for the treatment of multiple myeloma. Cancer Research. 73: 1020-1020. DOI: 10.1158/1538-7445.Am2013-1020  0.493
2011 Baughn LB, Stessman H, Mansoor A, Van Ness B. Modeling Proteasome Inhibition in Lymphoma Blood. 118: 4946-4946. DOI: 10.1182/Blood.V118.21.4946.4946  0.532
2011 Stessman H, Baughn LB, Sarver AG, Mansoor A, Wu TG, Janz S, Ness BV. Good and Poor Response Gene Expression Signatures to Proteasome Inhibitors Using a Mouse Model of Multiple Myeloma Blood. 118: 1843-1843. DOI: 10.1182/Blood.V118.21.1843.1843  0.516
2011 Stessman H, Baughn LB, Mansoor A, Van Ness B. Expression of Germinal Center B Cell Markers in Bortezomib-Resistant Multiple Myeloma Cells Blood. 118: 129-129. DOI: 10.1182/Blood.V118.21.129.129  0.522
Low-probability matches (unlikely to be authored by this person)
2020 Cheng H, Gottlieb L, Marchi E, Kleyner R, Bhardwaj P, Rope AF, Rosenheck S, Moutton S, Philippe C, Eyaid W, Alkuraya FS, Toribio J, Mena R, Prada CE, Stessman H, et al. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15. Human Molecular Genetics. PMID 32027362 DOI: 10.1093/Hmg/Ddz173  0.293
2020 Su F, Gm A, Palgunachari MN, White CR, Stessman H, Wu Y, Vadgama J, Pietras R, Nguyen D, Reddy ST, Farias-Eisner R. Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice. Journal of Cancer Research and Therapeutic Oncology. 8. PMID 32462055 DOI: 10.17303/Jcrto.2020.8.101  0.27
2015 Chen DH, Méneret A, Friedman JR, Korvatska O, Gad A, Bonkowski ES, Stessman HA, Doummar D, Mignot C, Anheim M, Bernes S, Davis MY, Damon-Perrière N, Degos B, Grabli D, et al. ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations. Neurology. PMID 26537056 DOI: 10.1212/Wnl.0000000000002058  0.27
2017 Cantsilieris S, Stessman HA, Shendure J, Eichler EE. Targeted Capture and High-Throughput Sequencing Using Molecular Inversion Probes (MIPs). Methods in Molecular Biology (Clifton, N.J.). 1492: 95-106. PMID 27822858 DOI: 10.1007/978-1-4939-6442-0_6  0.259
2016 Stessman HA, Turner TN, Eichler EE. Molecular subtyping and improved treatment of neurodevelopmental disease. Genome Medicine. 8: 22. PMID 26917491 DOI: 10.1186/s13073-016-0278-z  0.246
2020 Pope K, Doll J, Kyvelidou A, Stessman H, Nelson K, Jordan L. Clinician, caregiver and patient perspectives of the continuum of care for autism Journal of Interprofessional Education & Practice. 19: 100335. DOI: 10.1016/J.Xjep.2020.100335  0.242
2017 Stessman HA, Xiong B, Coe BP, Wang T, Hoekzema K, Fenckova M, Kvarnung M, Gerdts J, Trinh S, Cosemans N, Vives L, Lin J, Turner TN, Santen G, Ruivenkamp C, et al. Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Nature Genetics. PMID 28191889 DOI: 10.1038/Ng.3792  0.234
2016 Stessman HA, Willemsen MH, Fenckova M, Penn O, Hoischen A, Xiong B, Wang T, Hoekzema K, Vives L, Vogel I, Brunner HG, van der Burgt I, Ockeloen CW, Schuurs-Hoeijmakers JH, Klein Wassink-Ruiter JS, et al. Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders. American Journal of Human Genetics. 98: 541-552. PMID 26942287 DOI: 10.1016/J.Ajhg.2016.02.004  0.231
2019 Cheng H, Gottlieb L, Marchi E, Kleyner R, Bhardwaj P, Rope AF, Rosenheck S, Moutton S, Philippe C, Eyaid W, Alkuraya FS, Toribio J, Mena R, Prada CE, Stessman H, et al. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15. Human Molecular Genetics. PMID 31127942 DOI: 10.1093/hmg/ddz111  0.17
2016 Nuttle X, Giannuzzi G, Duyzend MH, Schraiber JG, Narvaiza I, Sudmant PH, Penn O, Chiatante G, Malig M, Huddleston J, Benner C, Camponeschi F, Ciofi-Baffoni S, Stessman HA, Marchetto MC, et al. Emergence of a Homo sapiens-specific gene family and chromosome 16p11.2 CNV susceptibility. Nature. PMID 27487209 DOI: 10.1038/Nature19075  0.168
2017 Küry S, Besnard T, Ebstein F, Khan TN, Gambin T, Douglas J, Bacino CA, Sanders SJ, Lehmann A, Latypova X, Khan K, Pacault M, Sacharow S, Glaser K, Bieth E, ... ... Stessman HA, et al. De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental Disorder. American Journal of Human Genetics. PMID 28132691 DOI: 10.1016/J.Ajhg.2017.01.003  0.151
2020 DeAngelo C, Tarasiewicz MB, Strother A, Taggart H, Gray C, Shanahan M, Glowacki C, Khandalavala J, Talaska E, Kinnan A, Coté JJ, Edwards AP, Harper-Harrison G, Casey MJ, Hirai TL, ... ... Stessman H, et al. Endometriosis: A Malignant Fingerprint. Journal of Cancer Research and Therapeutic Oncology. 8. PMID 33644256 DOI: 10.17303/jcrto.2020.8.206  0.148
2017 Küry S, Besnard T, Ebstein F, Khan TN, Gambin T, Douglas J, Bacino CA, Craigen WJ, Sanders SJ, Lehmann A, Latypova X, Khan K, Pacault M, Sacharow S, Glaser K, ... ... Stessman HA, et al. De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental Disorder. American Journal of Human Genetics. 100: 689. PMID 28388435 DOI: 10.1016/J.Ajhg.2017.03.003  0.06
Hide low-probability matches.